Published in Br J Clin Pharmacol on December 25, 2015
Limited Knowledge of Acetaminophen in Patients with Liver Disease. J Clin Transl Hepatol (2016) 0.75
Liver Illness and Psychiatric Patients. Hepat Mon (2016) 0.75
Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther (1973) 5.23
Studies in detoxication. 22. The metabolism of phenacetin (p-ethoxyacetanilide) in the rabbit and a further observation on acetanilide metabolism. Biochem J (1949) 4.74
Studies in detoxication: 16. The metabolism of acetanilide in the rabbit. Biochem J (1948) 4.10
Liver necrosis from paracetamol. Br J Pharmacol Chemother (1966) 3.77
Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial. Arch Intern Med (2001) 3.55
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA (2006) 3.49
Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet (2014) 3.35
Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet (1977) 3.00
The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol (2009) 2.78
Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum (1993) 2.49
Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet (2010) 2.32
Glutathione synthesis. Biochim Biophys Acta (2012) 2.11
Mildly elevated liver transaminase levels in the asymptomatic patient. Am Fam Physician (2005) 1.85
Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J Pharmacol Exp Ther (1983) 1.79
Acute ethanol coingestion confers a lower risk of hepatotoxicity after deliberate acetaminophen overdose. Acad Emerg Med (2008) 1.74
Influence of high body mass index on outcome in acute liver failure. Clin Gastroenterol Hepatol (2006) 1.74
Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis. Hepatology (2008) 1.73
The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients--a multicenter randomized study. BMC Med (2007) 1.69
Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease. Drug Metab Dispos (2009) 1.67
Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res (2013) 1.62
Disposition of acetaminophen at 4, 6, and 8 g/day for 3 days in healthy young adults. Clin Pharmacol Ther (2007) 1.61
A comparison of some pharmacological effects of acetophenetidin and N-acetyl p-aminophenol. Acta Physiol Scand (1953) 1.59
Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology (1995) 1.54
Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther (2001) 1.52
Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease. Drug Metab Dispos (2010) 1.48
Free amino acid and glutathione concentrations in muscle during short-term starvation and refeeding. Clin Nutr (2005) 1.47
Hepatotoxicity due to repeated intake of low doses of paracetamol. J Intern Med (1992) 1.46
Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin Pharmacol Ther (2000) 1.44
Dairy intake is associated with brain glutathione concentration in older adults. Am J Clin Nutr (2014) 1.41
Liver disease selectively modulates cytochrome P450--mediated metabolism. Clin Pharmacol Ther (2006) 1.29
Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc (2010) 1.24
The association of age and frailty with paracetamol conjugation in man. Age Ageing (1990) 1.22
Measurement of oxidized/reduced glutathione ratio. Methods Mol Biol (2010) 1.20
Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology (1995) 1.18
Up-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injury. World J Gastroenterol (2006) 1.14
A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol. Aliment Pharmacol Ther (2007) 1.12
A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother (1998) 1.11
Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. J Hepatol (2002) 1.10
Severe hepatotoxicity after therapeutic doses of acetaminophen. Clin Ther (2006) 1.07
Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity. Chem Res Toxicol (2006) 1.06
Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease. Drug Metab Dispos (2012) 1.05
Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis (2015) 1.04
Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clin Biochem (2010) 1.03
Acetaminophen kinetics in acutely poisoned patients. Clin Pharmacol Ther (1979) 1.03
Does therapeutic use of acetaminophen cause acute liver failure? Pharmacotherapy (2007) 1.02
Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen. Toxicology (2006) 1.01
Use of over-the-counter analgesics is not associated with acute decompensation in patients with cirrhosis. Clin Gastroenterol Hepatol (2009) 1.01
Overexpression of cytochrome P-450 isoforms involved in aflatoxin B1 bioactivation in human liver with cirrhosis and hepatitis. Toxicol Pathol (1997) 1.01
Glutathione and GSH-dependent enzymes in patients with liver cirrhosis and hepatocellular carcinoma. Acta Biochim Pol (2006) 1.00
Paracetamol metabolism in chronic liver disease. Eur J Clin Pharmacol (1979) 0.99
Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults. Clin Pharmacol Ther (2000) 0.99
Ketorolac and acetaminophen for orthopedic postoperative pain. Clin Pharmacol Ther (1986) 0.99
Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. J Hepatol (1999) 0.98
Analgesic efficacy of acetaminophen 1000 mg, acetaminophen 2000 mg, and the combination of acetaminophen 1000 mg and codeine phosphate 60 mg versus placebo in acute postoperative pain. Pharmacotherapy (1991) 0.95
The efficacy of ketoprofen and paracetamol (acetaminophen) in postoperative pain after third molar surgery. Br J Clin Pharmacol (1996) 0.94
Is there a place for cimetidine or ethanol in the treatment of paracetamol poisoning? Lancet (1983) 0.94
The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations. Hepat Mon (2014) 0.93
The effects of paracetamol (acetaminophen) on hepatic tests in patients who chronically abuse alcohol - a randomized study. Aliment Pharmacol Ther (2010) 0.93
Long-term ingestion of paracetamol and liver disease. J R Soc Med (1980) 0.93
Comparison of paracetamol metabolism in young adult and elderly males. Eur J Clin Pharmacol (1988) 0.93
Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease. Scand J Clin Lab Invest (2008) 0.92
Decreased production of glutathione in patients with cirrhosis. Eur J Clin Invest (1987) 0.92
Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr (2011) 0.91
Significance of plasma glutathione determination in patients with alcoholic and non-alcoholic liver disease. J Gastroenterol Hepatol (1992) 0.91
Effect of hospitalisation on liver enzymes in healthy subjects. Eur J Clin Pharmacol (2000) 0.91
Hepatic glutathione content in patients with alcoholic and non alcoholic liver diseases. Life Sci (1988) 0.90
Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials. Curr Med Res Opin (2006) 0.89
Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans. Clin Pharmacol Ther (1993) 0.88
Correlation of plasma and tissue oxidative stresses in intra-abdominal sepsis. J Surg Res (2004) 0.88
Vitamin B-6 restriction tends to reduce the red blood cell glutathione synthesis rate without affecting red blood cell or plasma glutathione concentrations in healthy men and women. Am J Clin Nutr (2009) 0.88
The effect of fasting on leukocyte and plasma glutathione and sulfur amino acid concentrations. Metabolism (1986) 0.88
Confusion: acetaminophen dosing changes based on NO evidence in adults. Drugs R D (2012) 0.87
Are recommended doses of acetaminophen hepatotoxic for recently abstinent alcoholics? A randomized trial. Clin Toxicol (Phila) (2008) 0.86
Glutathione status in the blood and tissues of patients with virus-originated hepatocellular carcinoma. Clin Biochem (2007) 0.86
Pharmacokinetics of intravenous paracetamol in elderly patients. Clin Pharmacokinet (2011) 0.85
Protective effect of ethanol against acetaminophen-induced hepatotoxicity in mice: role of NADH:quinone reductase. Biochem Pharmacol (1999) 0.85
A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administration. BMC Pharmacol Toxicol (2014) 0.85
The effect of mild alcohol consumption on the metabolism of acetaminophen in man. Res Commun Chem Pathol Pharmacol (1982) 0.85
The fate of acetanilide in man. J Pharmacol Exp Ther (1948) 0.84
Influence of acetaminophen at therapeutic doses on surrogate markers of severity of acute viral hepatitis. Gastroenterol Clin Biol (2006) 0.84
Glutathione kinetics in normal man and in patients with liver cirrhosis. J Hepatol (1997) 0.84
Dose-related effects of oral acetaminophen on cold-induced pain: a double-blind, randomized, placebo-controlled trial. Clin Pharmacol Ther (1998) 0.84
Preventative hepatology: minimising symptoms and optimising care. Liver Int (2008) 0.84
Inhibition of the metabolism of paracetamol by isoniazid. Br J Clin Pharmacol (1991) 0.84
Acute liver failure following therapeutic paracetamol administration in patients with muscular dystrophies. Anaesthesia (2008) 0.84
Analgesia for the cirrhotic patient: a literature review and recommendations. J Gastroenterol Hepatol (2014) 0.83
Involvement of cytochromes P-450 2E1 and 3A4 in the 5-hydroxylation of salicylate in humans. Drug Metab Dispos (1999) 0.83
Time course of total cysteine, glutathione and homocysteine in plasma of patients with chronic hepatitis C treated with interferon-alpha with and without supplementation with N-acetylcysteine. J Hepatol (1998) 0.83
Single and multiple dose pharmacokinetics of acetaminophen (paracetamol) in polymedicated very old patients with rheumatic pain. J Rheumatol (2001) 0.82
The effect of acetaminophen administration on its disposition and body stores of sulphate. Eur J Clin Pharmacol (1986) 0.82
Analgesic efficacy after single and repeated doses of codeine and acetaminophen. J Clin Pharmacol (1984) 0.82
Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease. Liver Int (2014) 0.81
Drug interactions with paracetamol. Am J Ther (2005) 0.80
Oxidative stress and antioxidant status in patients with autoimmune liver diseases. Redox Rep (2014) 0.80
Effect of a concomitant single dose of ethanol on the hepatotoxicity and metabolism of acetaminophen in mice. Toxicology (1980) 0.80
Acetaminophen in chronic liver disease. Clin Pharmacol Ther (1983) 0.80
Relationship between the severity of alcoholic liver cirrhosis and the metabolism of caffeine in 226 patients. Int J Clin Pharmacol Ther (2000) 0.80
Relationship between antioxidant capacity and oxidative stress in children with acute hepatitis A. World J Gastroenterol (2006) 0.80
Increased oxidative metabolism of paracetamol in patients with hepatocellular carcinoma. Cancer Lett (1991) 0.79
Pharmacokinetic variations of acetaminophen according to liver dysfunction and portal hypertension status. Aliment Pharmacol Ther (2004) 0.79